• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床、生化及横断面影像学特征在预测胰腺潜在恶性或恶性囊性病变方面的效用如何?来自一家机构对220例接受手术治疗患者的经验结果。

How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients.

作者信息

Goh Brian K P, Tan Yu-Meng, Thng Choon-Hua, Cheow Peng-Chung, Chung Yaw-Fui Alexander, Chow Pierce K H, Wong Wai-Keong, Ooi London L P J

机构信息

Department of Surgery, Singapore General Hospital, Singapore.

出版信息

J Am Coll Surg. 2008 Jan;206(1):17-27. doi: 10.1016/j.jamcollsurg.2007.06.312. Epub 2007 Oct 1.

DOI:10.1016/j.jamcollsurg.2007.06.312
PMID:18155564
Abstract

BACKGROUND

This study aims to determine the use of preoperative clinical, biochemical, and cross-sectional imaging features for predicting malignancy in cystic lesions of the pancreas (CLP).

STUDY DESIGN

Two hundred twenty patients who underwent operations for CLP or suspected CLP were reviewed. Patients were divided into two groups, patients undergoing operations for pseudocysts and patients undergoing operations for suspected cystic neoplasms. The predictive effect of various preoperative factors on the malignant potential of CLP was evaluated.

RESULTS

Forty-four patients with a preoperative diagnosis of pseudocysts underwent operations for complications of pseudocyst. Forty-two were confirmed pathologically to have pseudocysts, but two were found, unexpectedly, to harbor malignant lesions. One hundred seventy-six patients underwent operations for suspected pancreatic cystic neoplasms. There were 70 benign, 51 potentially malignant, and 55 malignant CLP. On multivariate analysis, three factors, ie, elevated serum carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9; cyst size > 3 cm; and presence of one or more of three morphologic features, such as solid component; peripheral calcification; and main duct dilation on cross-sectional imaging were independent predictors of malignancy. Presence of two or three of these factors had a positive predictive value of 88% in predicting a premalignant or malignant CLP.

CONCLUSIONS

Most pancreatic pseudocysts can be accurately diagnosed preoperatively. In patients with suspected pancreatic cystic neoplasms, elevated serum CEA or carbohydrate antigen 19-9, cyst size > 3 cm, and presence of suspicious morphologic features on imaging are predictors of potentially malignant or malignant CLP. Patients with a high likelihood of a potentially malignant or malignant lesion based on these three factors should undergo operation without additional investigations.

摘要

背景

本研究旨在确定术前临床、生化及横断面成像特征在预测胰腺囊性病变(CLP)恶性程度方面的应用。

研究设计

回顾了220例行CLP或疑似CLP手术的患者。患者分为两组,一组为行假性囊肿手术的患者,另一组为行疑似囊性肿瘤手术的患者。评估了各种术前因素对CLP恶性潜能的预测作用。

结果

44例术前诊断为假性囊肿的患者因假性囊肿并发症接受手术。42例经病理证实为假性囊肿,但意外发现2例存在恶性病变。176例患者因疑似胰腺囊性肿瘤接受手术。其中70例为良性CLP,51例为潜在恶性CLP,55例为恶性CLP。多因素分析显示,血清癌胚抗原(CEA)或糖类抗原19-9升高、囊肿大小>3 cm以及横断面成像存在实性成分、周边钙化和主胰管扩张这三种形态学特征中的一种或多种这三个因素是恶性的独立预测因素。存在其中两个或三个因素对预测癌前或恶性CLP的阳性预测值为88%。

结论

大多数胰腺假性囊肿术前可准确诊断。对于疑似胰腺囊性肿瘤的患者,血清CEA或糖类抗原19-9升高、囊肿大小>3 cm以及成像存在可疑形态学特征是潜在恶性或恶性CLP的预测因素。基于这三个因素高度怀疑存在潜在恶性或恶性病变的患者应直接接受手术,无需进一步检查。

相似文献

1
How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients.临床、生化及横断面影像学特征在预测胰腺潜在恶性或恶性囊性病变方面的效用如何?来自一家机构对220例接受手术治疗患者的经验结果。
J Am Coll Surg. 2008 Jan;206(1):17-27. doi: 10.1016/j.jamcollsurg.2007.06.312. Epub 2007 Oct 1.
2
Cystic neoplasms of the pancreas: problems in differential diagnosis.胰腺囊性肿瘤:鉴别诊断中的问题
Am Surg. 1993 Nov;59(11):740-5.
3
Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years.胰腺囊性病变:对某一机构在15年间所采用的积极切除策略的评估。
Am J Surg. 2006 Aug;192(2):148-54. doi: 10.1016/j.amjsurg.2006.02.020.
4
Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.《仙台和福冈关于胰腺黏液性囊性肿瘤的共识指南对所有疑似胰腺囊性肿瘤的初始分诊是否有用?一项针对317例接受手术治疗患者的单机构经验》
Ann Surg Oncol. 2014 Jun;21(6):1919-26. doi: 10.1245/s10434-014-3501-4. Epub 2014 Feb 7.
5
Non-neoplastic cystic and cystic-like lesions of the pancreas: may mimic pancreatic cystic neoplasms.胰腺的非肿瘤性囊性和类囊性病变:可能酷似胰腺囊性肿瘤。
ANZ J Surg. 2006 May;76(5):325-31. doi: 10.1111/j.1445-2197.2006.03718.x.
6
Is there an indication for initial conservative management of pancreatic cystic lesions?胰腺囊性病变初始保守治疗是否有指征?
J Surg Oncol. 2009 Oct 1;100(5):372-4. doi: 10.1002/jso.21260.
7
Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively.胰腺黏液高分泌性肿瘤:术前评估恶性程度
Am J Surg. 1996 Apr;171(4):427-31. doi: 10.1016/S0002-9610(97)89624-9.
8
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.端粒酶活性是区分恶性胰腺囊性肿瘤与良性肿瘤及假性囊肿的有用标志物。
J Surg Res. 1999 Dec;87(2):171-7. doi: 10.1006/jsre.1999.5699.
9
Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.血清肿瘤标志物和囊液分析对胰腺囊性肿瘤的诊断有帮助。
Cancer. 1996 Jul 15;78(2):237-43. doi: 10.1002/(SICI)1097-0142(19960715)78:2<237::AID-CNCR8>3.0.CO;2-I.
10
International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.国际共识指南对于黏液性肿瘤的外科切除并不能适用于所有胰腺囊性病变。
Clin Gastroenterol Hepatol. 2009 Dec;7(12):1373-6. doi: 10.1016/j.cgh.2009.06.026. Epub 2009 Jul 1.

引用本文的文献

1
Diagnostic, Structured Classification and Therapeutic Approach in Cystic Pancreatic Lesions: Systematic Findings with Regard to the European Guidelines.胰腺囊性病变的诊断、结构化分类及治疗方法:关于欧洲指南的系统研究结果
Diagnostics (Basel). 2023 Jan 26;13(3):454. doi: 10.3390/diagnostics13030454.
2
A Case of Choledocholithiasis and Obstructive Jaundice With a Very High Serum Carbohydrate Antigen 19-9 (CA 19-9) Level: A Case Report and Review of Literature.一例血清糖类抗原19-9(CA 19-9)水平极高的胆总管结石合并梗阻性黄疸病例报告及文献复习
Cureus. 2022 Dec 12;14(12):e32447. doi: 10.7759/cureus.32447. eCollection 2022 Dec.
3
MR quantitative 3D shape analysis helps to distinguish mucinous cystic neoplasm from serous oligocystic adenoma.
磁共振定量 3D 形态分析有助于鉴别黏液性囊腺瘤和浆液性微囊性腺瘤。
Diagn Interv Radiol. 2022 May;28(3):193-199. doi: 10.5152/dir.2022.20738.
4
The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy.新型胰腺癌预后指数在接受确定性同步放化疗的不可切除局部晚期胰腺癌中的预后意义
J Inflamm Res. 2021 Sep 4;14:4433-4444. doi: 10.2147/JIR.S329611. eCollection 2021.
5
Cystic pancreatic lesions, the endless dilemma.胰腺囊性病变,无尽的困境。
World J Gastroenterol. 2021 Jun 7;27(21):2664-2680. doi: 10.3748/wjg.v27.i21.2664.
6
Carbohydrate antigen 19-9 - tumor marker: Past, present, and future.糖类抗原19-9——肿瘤标志物:过去、现在与未来
World J Gastrointest Surg. 2020 Dec 27;12(12):468-490. doi: 10.4240/wjgs.v12.i12.468.
7
Pancreatic cystic neoplasm diagnosis: Role of imaging.胰腺囊性肿瘤的诊断:影像学的作用。
Endosc Ultrasound. 2018 Sep-Oct;7(5):297-300. doi: 10.4103/eus.eus_38_18.
8
[Early stage pancreatic cancer].[早期胰腺癌]
Chirurg. 2018 Apr;89(4):257-265. doi: 10.1007/s00104-017-0569-y.
9
Imaging modalities for characterising focal pancreatic lesions.用于表征胰腺局灶性病变的成像方式。
Cochrane Database Syst Rev. 2017 Apr 17;4(4):CD010213. doi: 10.1002/14651858.CD010213.pub2.
10
Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.血清糖类抗原19-9在胰腺囊性肿瘤良恶性鉴别诊断中的Meta分析
PLoS One. 2016 Nov 11;11(11):e0166406. doi: 10.1371/journal.pone.0166406. eCollection 2016.